Detection assay of polymyxin resistance coding mcr-1 gene based on CRISPR/Cas13a system

Yingjie Song1, Qiang Hu1, Yao Han1

  • 1State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China.

Abstract

Insights

A new CRISPR/Cas13a assay with lateral flow strips can detect the polymyxin resistance gene mcr-1. This portable method is suitable for primary healthcare and field surveillance of multidrug-resistant bacteria.

Area of Science:

  • Microbiology
  • Molecular Biology
  • Antimicrobial Resistance

Background:

  • Polymyxins are crucial for treating multidrug-resistant Gram-negative bacterial infections.
  • The emergence of the mcr-1 gene confers polymyxin resistance, posing a significant threat to public health.
  • Accurate and rapid detection of mcr-1 is essential for guiding treatment and controlling resistance spread.

Purpose of the Study:

  • To develop a sensitive and portable method for detecting the mcr-1 gene.
  • To evaluate the performance of the developed assay compared to quantitative real-time PCR (qPCR).

Main Methods:

  • CRISPR/Cas13a system combined with lateral flow strips was utilized for mcr-1 gene detection.
  • Assay optimization and validation were performed using clinical isolates of Escherichia coli.
  • Comparison with qPCR was conducted to assess accuracy and concordance.

Main Results:

  • A detection limit of 100 copies/mL was achieved for the mcr-1 gene.
  • The assay demonstrated high analytical specificity, with no cross-reactivity observed.
  • 100% concordance with qPCR results was observed for 36 clinical isolates, correctly identifying 31 mcr-1 positive strains.

Conclusions:

  • A novel CRISPR/Cas13a-based detection method for the mcr-1 gene was successfully established.
  • The assay provides visual readouts without requiring specialized equipment, enhancing portability.
  • This method holds potential for application in primary healthcare settings and field surveillance of polymyxin resistance.

Related Concept Videos

CRISPR01:59

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
53.0K
CRISPR and crRNAs02:53

CRISPR and crRNAs

Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.5K
CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
375
The Antiviral System of Bacteria and Archaea: CRISPR01:23

The Antiviral System of Bacteria and Archaea: CRISPR

CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
138